Clinical Trials Logo

Depression, Bipolar clinical trials

View clinical trials related to Depression, Bipolar.

Filter by:

NCT ID: NCT00608296 Completed - Depression, Bipolar Clinical Trials

Functional and Neurochemical Brain Changes Bipolar Depression

Start date: January 2008
Phase: N/A
Study type: Observational

The purpose of the research is to study brain structure, function and chemistry of patients with bipolar disorder who are receiving quetiapine or lithium, in order to better understand who benefits from treatment and why they respond to medications.

NCT ID: NCT00590265 Active, not recruiting - Depression, Bipolar Clinical Trials

Light-Therapy in the Treatment of the Acute Phase of the Bipolar Type II Depression

BPII-DEP-LT
Start date: January 2008
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the efficacy and safety of light therapy for the treatment of bipolar type II patients relapsing into a depressive phase during autumn or winter.

NCT ID: NCT00510146 Completed - Depression, Bipolar Clinical Trials

Olanzapine Treatment of Patients With Bipolar I Disorder

Start date: August 2007
Phase: Phase 3
Study type: Interventional

The purpose of this study is to assess whether olanzapine is superior to placebo in patients with bipolar depression.

NCT ID: NCT00483548 Completed - Bipolar Disorder Clinical Trials

Adjunctive Ziprasidone in the Treatment of Bipolar I Depression

Start date: October 2007
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine if a treatment regimen of ziprasidone plus a mood stabilizer is safe and effective in the short term treatment of Bipolar I Depression. Ziprasidone will be added to lithium, valproate or lamotrigine after the patient has been on a therapeutic dose of one of these mood stabilizers for at least 4 weeks.

NCT ID: NCT00422214 Completed - Depression, Bipolar Clinical Trials

Phase III/Seroquel SR Bipolar Depression Monotherapy - US

Start date: December 2006
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine the safety and efficacy of sustained-release quetiapine fumarate (Seroquel®) in the treatment of patients with Acute Bipolar Depression for 8 weeks. PLEASE NOTE: Seroquel SR and Seroquel XR refer to the same formulation. The SR designation was changed to XR after consultation with FDA.

NCT ID: NCT00245973 Completed - Depression Bipolar Clinical Trials

Study Evaluating Bifeprunox in Bipolar Depression

Start date: June 2005
Phase: Phase 3
Study type: Interventional

The purpose of the study is to investigate whether eight weeks of treatment with flexible doses of Bifeprunox is superior to treatment with placebo in depressed patients with bipolar disorder.

NCT ID: NCT00191399 Completed - Depression, Bipolar Clinical Trials

Bipolar Depression Study: Bipolar Depression Assessment Study on Treatment Response

Start date: May 2004
Phase: Phase 4
Study type: Interventional

The primary objective of this study is to assess the efficacy of olanzapine and fluoxetine combined on all the visits as compared with the baseline visit in patients with bipolar disorder, measured by the total score of the Montgomery-Asberg Depression Rating Scale (MADRS).

NCT ID: NCT00186186 Completed - Depression, Bipolar Clinical Trials

Depakote ER in Bipolar Depression

Start date: January 2004
Phase: Phase 4
Study type: Interventional

The purpose of this study is to examine the safety and efficacy of Depakote ER in bipolar depression and to evaluate metabolic and GABA changes with Depakote ER administration using PET and MRI/MRS brain imaging techniques.

NCT ID: NCT00060489 Completed - Bipolar Disorder Clinical Trials

Safety and Efficacy Trial of the Use of Quetiapine Fumarate (SEROQUEL®) in the Treatment of Patients With Bipolar Depression

Start date: September 2002
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the efficacy and safety of quetiapine in the treatment of a major depressive episode in patients with bipolar disorder.